What's in Universidad Nacional de La Plata's pipeline?

Universidad Nacional de La Plata has 2 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Universidad Nacional de La Plata's portfolio?

Top competitors by shared drug class: B. Braun Melsungen AG, Dalarna County Council, Sweden, Fundacion Clinica Valle del Lili, Montefiore Medical Center, Nanjing Chia-tai Tianqing Pharmaceutical.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/universidad-nacional-de-la-plata.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Universidad Nacional de La Plata — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Universidad Nacional de La Plata pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Resuscitation (Voluven)	Resuscitation (Voluven)	phase 3	Colloid plasma volume expander		Critical Care / Emergency Medicine
Resuscitation (Saline)	Resuscitation (Saline)	phase 3	Crystalloid fluid / Electrolyte replacement		Critical Care / Emergency Medicine

Therapeutic area mix

Critical Care / Emergency Medicine · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

B. Braun Melsungen AG · 1 shared drug class
Dalarna County Council, Sweden · 1 shared drug class
Fundacion Clinica Valle del Lili · 1 shared drug class
Montefiore Medical Center · 1 shared drug class
Nanjing Chia-tai Tianqing Pharmaceutical · 1 shared drug class
Rhode Island Hospital · 1 shared drug class
Rigshospitalet, Denmark · 1 shared drug class
Seoul National University Hospital · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Universidad Nacional de La Plata:

Cite this brief

Drug Landscape (2026). Universidad Nacional de La Plata — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/universidad-nacional-de-la-plata. Accessed 2026-05-18.